Showing 6201-6210 of 8708 results for "".
- Coping with COVID-19: Tips and Tools for Enhancing Virtual Skin Cancer Examshttps://practicaldermatology.com/news/coping-with-covid-19-tips-and-tools-for-enhancing-virtual-skin-cancer-exams-1/2460356/Dermatologists across the country have shut their doors due to the coronavirus pandemic, and little certainty remains about when they will reopen for business as usual. Many are still seeing patients with aggressive squamous cell carcinoma or melanoma, but these patients need to be effectively tr
- Industry Responds to COVID-19: UCB, Galderma, Timeless Skin Carehttps://practicaldermatology.com/news/industry-responds-to-covid-19-ucb-galderma-timeless-skin-care/2460354/UCB. UCB is working with the Seattle Structural Genomics Center for Infectious Disease to identify crystal structures of SARS-CoV-2 proteins. In addition to provi
- DermWire Exclusive: Inside the COVID-19 Outbreak in Italy with Dr. Sebastiano Recalcatihttps://practicaldermatology.com/news/dermwire-covid-19-exclusive-inside-the-outbreak-in-italy-with-sebastiano-recalcati/2460352/Dr. Sebastiano Recalcati, a dermatologist in Lombardy, Italy, was one of many doctors called to the frontlines in that country when COVID-19 ravaged the region. He published his observations in the Journal
- Finacea Foam Back in Pharmacies: LEO Pharmahttps://practicaldermatology.com/news/finacea-foam-back-in-pharmacies-leo-pharma/2460347/After a shortage due to production delays, Finacea®(azelaic acid) Foam, 15% is now available, LEO Pharma says. Finacea Foam is the first and only prescription foam FDA approved for the treatment of rosacea. It is a light water-based (hydrophilic) foam that is alcohol-free and fragrance free.<
- Industry Responds to COVID-19: E.T. Browne Drug Co., Columbia University Medical Center, RealSelfhttps://practicaldermatology.com/news/industry-responds-to-covid-19-et-browne-drug-co-realself-hydrafacial-thrive-causemetics/2460345/E.T. Browne Drug Co. The manufacturer of Palmer' Cocoa Butter Formula and Coconut Oil Formula skin and hair care products is now producing medical-grade hand sanitizer to address widespread supply shortages in the wake of COVID-19. Initial production of the disinfectant sanit
- Industry Responds to COVID-19: Henry Schein Medical, PCA Skinhttps://practicaldermatology.com/news/industry-responds-to-covid-19-henry-schein-medical-pca-skin/2460344/Henry Schein Medical. Henry Schein Medical is making
- Rosacea Awareness Month Brings Focus to Common Skin Diseasehttps://practicaldermatology.com/news/rosacea-awareness-month-brings-focus-to-common-skin-disease/2460342/It’s Rosacea Awareness Month, and the National Rosacea Society (NRS) continues to educate the public on this potentially serious condition estimated to affect more than 16 million Americans. “Although the occurrence of rosacea has been well documented over the centuries, vir
- Industry Responds to COVID-19: E.T. Browne Drug Co., Columbia University Medical Center, RealSelfhttps://practicaldermatology.com/news/industry-responds-to-covid-19-def-leo-pharma-dermyoung-coty/2460329/E.T. Browne Drug Co. The manufacturer of Palmer' Cocoa Butter Formula and Coconut Oil Formula skin and hair care products is now producing medical-grade hand sanitizer to address widespread supply shortages in the wake of COVID-19. Initial production of the disinfectant sanit
- BiomX’s BX001 for Acne-Prone Skin Performs Well in Phase 1 Trialhttps://practicaldermatology.com/news/biomxs-bx001-for-acne-prone-skin-performs-well-in-phase-1-1/2460328/BiomX Inc.’s lead candidate BX001 for acne-prone skin met its primary endpoint of safety and tolerability for both doses of BX001 as well as a statistically significant reduction of Cutibacterium acnes (C. acnes) levels for the high dos
- Industry Responds to COVID-19: Allergan Foundation; AG Hair; Revancehttps://practicaldermatology.com/news/industry-responds-to-covid-19-allergan-foundation-ag-hair-revance/2460326/Allergan. Of the approximately $13 million in charitable grants the Allergan Foundation has awarded in 2020, a total of $2 million will be dedicated to more than 70 organizations responding to the local impact of the COVID-19 pandemic. Other grant recipients i